Barclays PLC (BARC)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 422.05 |
|---|---|
| 52-week range | 361.35 – 538.30 |
| Return, 1 month / 3 months | −9.0% / −19.5% |
| Return, 1 year / 3 years | +11.2% / +258.9% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 30.1% |
| Worst drawdown (1 year) | -24.6% |
| Average daily value traded | 18,381.93M GBX |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Barclays PLC is a British bank based in London. It serves personal customers and small businesses through retail and business banking, credit cards and wealth management, and it provides corporate and investment banking, lending and markets services to large companies and institutional clients. Its operations span the United Kingdom, Europe, the Americas, Africa and Asia, and its investment bank works with corporations and governments on financing and advisory work.
Barclays PLC trades under the code BARC on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Barclays PLC (BARC) trades on the London Stock Exchange in UK. It last closed at GBX 422.05 on 27 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 1,673 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.2% and over the last three months it fell 19.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.1% | ||
| From 52-week high | -20.4% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -19.5% | ||
| 6-month return | -0.1% | ||
| 12-month return, skipping the last month | 22.2% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.6% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 18,381.93M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.8% |
|---|---|
| 1 month | −9.0% |
| 3 months | −19.5% |
| 6 months | −0.1% |
| 1 year | +11.2% |
| 3 years | +258.9% |
| 5 years | +152.8% |
Signals
| 50-day / 200-day average | 461.89 / 459.26 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 14.29 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Aug 2026 | GBP 0.0590 |
| 19 Feb 2026 | GBP 0.0560 |
| 7 Aug 2025 | GBP 0.0300 |
| 27 Feb 2025 | GBP 0.0550 |
| 15 Aug 2024 | GBP 0.0290 |
| 29 Feb 2024 | GBP 0.0530 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.